[Protective effect of PGI2 on experimental ARDS and factors influencing it].
Zhou
Y G
YG
Wang
Z G
ZG
Zhou
B T
BT
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D011464:Epoprostenol / Q000627:therapeutic use*; D007052:Ibuprofen / Q000627:therapeutic use; D008297:Male; D009829:Oleic Acids; D011817:Rabbits; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000188:drug therapy*; D013929:Thromboxane B2 / Q000097:blood
D009829:Oleic Acids; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol; D007052:Ibuprofen